TALi’s evidence-based game offers early intervention for ADHD

Globally, 136 million children have severe attention difficulties which in many cases presents as a diagnosis of ADHD. In Australia alone, ADHD costs the economy $20 billion a year.

Globally, 136 million children have severe attention difficulties which in many cases presents as a diagnosis of ADHD. In Australia alone, ADHD costs the economy $20 billion a year.

Early childhood, when the brain is at its highest developmental period, is the best time to screen for attention disorders and deliver therapies that help children have better health and educational outcomes. 

TALi Digital (ASX: TD1) is a digital health platform that assesses children with attention difficulties and strengthens attention leading to improved cognitive performance.

While attention-related disorders are often treated with medications, many clinicians are now looking for non-drug based therapies to use in these early years. 

Digital cognitive assessment and training platforms are of particular interest. As a result, this field is projected to become an $8 billion market by 2021, a 32% increase since 2016.

Supported by 25 years of research and clinical trials, TALi is a patented medical device that has shown commercial viability through its early release to the Australian market. 


“We’ve started locally. There are about 1.9 million children in Australia who have attention issues. We’re really focused on collecting data in those early years so we can replicate that in other larger markets in 2021,” said Managing Director Glen Smith in his presentation for ‘The Insiders’.


TALi has regulatory clearances in the US, Europe and Australia.

Although the target is currently children aged 3 to 8 years old, TALi is looking to expand into wider age groups and cognitive issues.

“Our R&D program looks at the teenage and adult populations. ADHD, ASD and other cognitive and behavioural disorders are a very large issue globally so we’re focused on working towards phased trials in those populations,” said Managing Director Glenn Smith when he spoke at ‘The Insiders’.


“We’re also looking at novel populations including in the area of dementia and how disease progression may be varied through non-invasive digital therapies. So that’s going to build long term value in what we’re doing as an organisation,” he said.


Thanks to TALi Digital’s partnerships globally including with Google Education, the company expects to reach 1 million children by 2023.

Along with product evolution and government contracts, this partnership is expected to be the backbone of the TALi’s revenue growth and profitability.


TALi Digital’s Managing Director Glenn Smith joined us for the previous episode of ‘The Insider’. You can watch a recording of the session below, or you can click here to book into our next session.

‘The Insider’ is a great way to hear directly from the CEOs of fast growing Australian businesses. You will get valuable insights to their industries and companies future prospects.

The Insider – Event Details:

Date: Wednesday, 18th November Time: 12 pm AEDT Format: Online, 3 x 15 minute presentations

This is a free event. Click here to book your spot.


This Week’s News


13 June 2024

Breaking News!!! Plutonic’s Kris Butera


31 May 2024

Top geo backed by leading resources funds believes he has discovered a potential new gold-copper district


8 May 2024

BHP Xplor winner coming to the ASX

General Advice Warning

Any advice provided by Reach Markets including on its website and by its representatives is general advice only and does not consider your objectives, financial situation or needs, and you should consider whether it is appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice. If you are thinking about acquiring a financial product, you should consider our Financial Services Guide (FSG)

including the Privacy Statement and any relevant Product Disclosure Statement or Prospectus (if one is available) to understand the features, risks and returns associated with the investment.

Please click here to read our full warning.